Top Empty Capsules Manufacturing Companies : Pharma CMOs

ACG Worldwide LogoQualicaps LogoHealthcaps India Ltd LogoErawat Pharma Limited LogoSuheung Capsule(Suheung Co., Ltd.) LogoCapsCanada LogoZhejiang Huili Capsules Co., Ltd. Logo

For  more updates follow Pharmed Intel

Drop us a note on our email id for specific Pharmed Info

Advertisements

Top companies involved in micronization of APIs

MICRO-MACINAZIONE S.A. Now a Lonza Company LogoF.P.S. Food and Pharma Systems srl LogomiBEC (division of BEC Chemicals) LogoNeo-Advent Technologies, LLC LogoMUNIT SA Logo

Below is quick note about capabilities of these companies:

Neo-Advent Technologies LLC

Neo-Advent Technologies LLC offer a vast array of preclinical development services in drug formulation, analytical and bioanalytical characterization in support of pharmaceuticals, biopharmaceuticals and medical devices. The Company works with all drug forms with a particular expertise in micronization, milling and particle size reduction as well as drug delivery, polymer and biopolymers modifications and analysis. We run an integrated custom synthesis lab and a pilot production and purification suite.

MUNIT

MUNIT is a new and innovative consultancy company, operating in the field of MICRONIZATION of Active Pharmaceutical Ingredients (APIs), High Potent APIs, Cytotoxic and Cytostatic compounds, Inhalation products, Steroids, R&D compounds and Generics.

MICRO-MACINAZIONE S.A. Now a Lonza Company

With over 40 years of experience, swiss-based Micro-Macinazione S.A. is the most competent provider of Micronization services and equipment for the Pharmaceutical & Fine Chemical industry.

FPS Food and Pharma Systems

FPS Food and Pharma Systems is a leading company in the containment and micronization fields, developing, manufacturing and installing worldwide its own range of Milling and Micronization Systems and Containment Solutions (for both sterile and toxic applications).

Mi -BEC

Mi -BEC is a division of BEC Chemicals established in 2016, located at Mahape (Navi Mumbai). We are specialized in Micronization of Active Pharmaceutical Ingredients (API’s).

For more updates follow Pharmmed Intel

Looking for inhaler devices CMO : Look no more, Recipharm has got it all

2017_Recipharm

Looking for inhaler devices CMO?  Look no more, Recipharm has got it all…

The acquisition of Sanofi’s manufacturing centre in Holmes Chapel just goes about highlighting  Recipharm’s  pro-activeness in becoming a strategic partner for global pharma in respiratory drug market. This move also scales up commercial available capacity of Recipharm, now that its US capacity sees addition from this newly added plant.

Company Quotes

Thomas Eldered, CEO of Recipharm, commented: “Holmes Chapel brings Recipharm an ideal opportunity to accelerate its offering to customers with access to novel of respiratory products. As an already successful CMO with several clients, we look forward to introducing new contracts to Holmes Chapel by utilising our growing franchise in development services. Treatments for asthma and chronic obstructive pulmonary disease (COPD) are growing at a fast rate and we see many opportunities. The experienced management team and staff have already successfully attracted new customers and we look forward to building on this from the well invested facility.

We all know how various CMOs are striving hard to offer not just quality but also cost competitiveness to Pharma buyers. With expansion like Recipharm’s ,the companies could leverage economies of scale and provide buyers with much better price, and not to forget best in class product. As  CMO market evolves we wait for more actions of similar sort that would re-define the future of pharma outsourcing.

Watch out for more updates around Recipharm, one of the leading CDMO by following Pharmed Intel.

Top Pharma API and Finished Dosage Formulators

Quick visualization of US FDA audited companies have been captured in info-graphics GDUFAbelow. Regulatory data have been used as feed stock for these deductions.

Trailblazers across various areas have been highlighted in visualization. Some of the major observations have been outlined below:

  1.  Year 2016 witnessed dip in overall FDA audited facility counts.
  2. While Sanofi led the FDA approved facility count in API space, Mylan was forerunner in finished dosage segment.
  3. India witnessed highest facility count increase in API space, while Taiwan enjoyed  number 1 position in terms of increase in FDF approved facilities for the year trailing 2016-2017.

Note: Analysis was carried on data sets which was not very organized at company name level, hence some of the prominent entries might be missing from visualization.